OPPORTUNITIES OF DORNASE ALFA IN PEDIATRICS

OPPORTUNITIES OF DORNASE ALFA IN PEDIATRICS

Show other versions (1)

Early treatment with Pulmozyme (dornase alfa) and its prolonged use in combination with basis therapy results in decrease of exacerbation rate, prolongation of remission of bronchopulmonary process with normal ventilation functions of lungs and gives patients with cystic fibrosis an opportunity to l...

Full description

Bibliographic Details
Main Author:	O.I. Simonova
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2011-07-01
Series:	Voprosy Sovremennoj Pediatrii
Online Access:	https://vsp.spr-journal.ru/jour/article/view/659

Similar Items

OPPORTUNITIES OF DORNASE ALFA IN PEDIATRICS
by: O.I. Simonova
Published: (2011-01-01)

DORNASE ALFA: WHAT EFFECTIVENESS OF MEDICATION DEPENDS ON?
by: O.I. Simonova
Published: (2009-07-01)

DORNASE ALFA: WHAT EFFECTIVENESS OF MEDICATION DEPENDS ON?
by: O.I. Simonova
Published: (2009-01-01)

AN IMPORTANT COMPONENT OF BASIC THERAPY IN CYSTIC FIBROSIS (MUCOVYSCIDOSIS) IN CHILDREN: DORNASE ALFA
by: O.I. Simonova
Published: (2011-10-01)

AN IMPORTANT COMPONENT OF BASIC THERAPY IN CYSTIC FIBROSIS (MUCOVYSCIDOSIS) IN CHILDREN: DORNASE ALFA
by: O.I. Simonova
Published: (2011-10-01)

PECULIARITIES OF DORNASE ALFA AND KINESITHERAPY USE IN CHILDREN WITH CYSTIC FIBROSIS
by: O. I. Simonova
Published: (2013-07-01)

DORNASE ALPHA: THREE CLINICAL EFFECTS
by: O.I. Simonova
Published: (2008-03-01)

DORNASE ALPHA: THREE CLINICAL EFFECTS
by: O.I. Simonova
Published: (2008-03-01)

A MUCOLYTIC WITH ANTIINFLAMMATORY QUALITIES FOR CHILDREN SUFFERED FROM CYSTIC FIBROSIS: DORNASE ALFA
by: O. I. Simonova, et al.
Published: (2012-12-01)

DORNASE ALFA IN RUSSIA: 15 YEARS LATER. EFFICACY OF THE DRUG IN THE BASIC TREATMENT IN CHILDREN WITH CYSTIC FIBROSIS
by: O. I. Simonova, et al.
Published: (2012-03-01)

Aerosol Delivery of Dornase Alfa Generated by Jet and Mesh Nebulizers
by: Kyung Hwa Chang, et al.
Published: (2020-07-01)

Additive Effect of Dornase Alfa and Nacystelyn on Transportability and Viscoelasticity of Cystic Fibrosis Sputum
by: Feng Sun, et al.
Published: (2002-01-01)

RECURRENT POLYSINUSITIS AS LEADING CLINICAL EVIDENCE OF CYSTIC FIBROSIS. SUCCESSFUL ENDONASAL APPLICATION OF DORNASE ALFA
by: I.K. Asherova, et al.
Published: (2009-10-01)

RECURRENT POLYSINUSITIS AS LEADING CLINICAL EVIDENCE OF CYSTIC FIBROSIS. SUCCESSFUL ENDONASAL APPLICATION OF DORNASE ALFA
by: I.K. Asherova, et al.
Published: (2009-10-01)

The Use of Dornase Alfa in the Management of COVID-19-Associated Adult Respiratory Distress Syndrome
by: Andrew Toma, et al.
Published: (2021-01-01)

Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome
by: A.P. Earhart, et al.
Published: (2020-05-01)

SPECIFIC DISORDERS OF THE RESPIRATORY SYSTEM IN CYSTIC FIBROSIS. CLINICAL EFFICACY OF THERAPY WITH DORNASE ALFA IN CHILDREN
by: T.V. Simanova, et al.
Published: (2010-11-01)

Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection
by: H.K. Okur, et al.
Published: (2020-09-01)

SPECIFIC DISORDERS OF THE RESPIRATORY SYSTEM IN CYSTIC FIBROSIS. CLINICAL EFFICACY OF THERAPY WITH DORNASE ALFA IN CHILDREN
by: T.V. Simanova, et al.
Published: (2010-11-01)

LONG TERM MUCOLYTIC THERAPY WITH DORNASE ALFA AT NOVOSIBIRSK CENTER FOR DIAGNOSTICS, TREATMENT, RHEABILITATION AND ADAPTATION OF CHILDREN WITH CYSTIC FIBROSIS
by: N.I. Romanenko, et al.
Published: (2006-03-01)

LONG TERM MUCOLYTIC THERAPY WITH DORNASE ALFA AT NOVOSIBIRSK CENTER FOR DIAGNOSTICS, TREATMENT, RHEABILITATION AND ADAPTATION OF CHILDREN WITH CYSTIC FIBROSIS
by: N.I. Romanenko, et al.
Published: (2006-01-01)

ESTIMATION OF THE MODERN MUCOLYTIC THERAPY EFFICACY IN CHILDREN, SUFFERING FROM MUCOVISCIDOSIS (TWO YEAR EXPERIENCE OF DORNASE ALFA APPLICATION)
by: E.B. Pavlinova, et al.
Published: (2007-03-01)

ESTIMATION OF THE MODERN MUCOLYTIC THERAPY EFFICACY IN CHILDREN, SUFFERING FROM MUCOVISCIDOSIS (TWO YEAR EXPERIENCE OF DORNASE ALFA APPLICATION)
by: E.B. Pavlinova, et al.
Published: (2007-01-01)

Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series
by: Andrew G. Weber, et al.
Published: (2020-09-01)

Sequential intrapleural administration of fibrinolytic drugs and dornase alfa for empyema management. Treatment protocol based on its physicochemical stability
by: Carla Bastida, et al.
Published: (2020-01-01)

Dornase alpha use in patients with cystic fibrosis
by: Paulo José C. Marostica
Published: (2013-12-01)

A first-year dornase alfa treatment impact on clinical parameters of patients with cystic fibrosis: the Brazilian cystic fibrosis multicenter study
by: Tatiana Rozov, et al.
Published: (2013-12-01)

MUCOLYTIC THERAPY IN PEDIATRICS: MYTHS AND REALITY
by: O.I. Simonova
Published: (2009-04-01)

MUCOLYTIC THERAPY IN PEDIATRICS: MYTHS AND REALITY
by: O.I. Simonova
Published: (2009-04-01)

Clinical efficacy and bleeding outcomes of tissue plasminogen activator and dornase alfa in pleural space infection with once daily concurrent administration: a retrospective cohort study
by: Chuan Jiang, et al.
Published: (2020-08-01)

Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial
by: Michael H. Livingston, et al.
Published: (2017-06-01)

Successful treatment of atelectasis with Dornase alpha in a patient with congenital muscular dystrophy
by: G. Crescimanno, et al.
Published: (2014-01-01)

Protocol for TRAUMADORNASE: a prospective, randomized, multicentre, double-blinded, placebo-controlled clinical trial of aerosolized dornase alfa to reduce the incidence of moderate-to-severe hypoxaemia in ventilated trauma patients
by: Julien Pottecher, et al.
Published: (2020-03-01)

Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial
by: J. P. Desilles, et al.
Published: (2020-06-01)

ADMINISTRATION OF MUCOLYTICS WITH DIRECT ACTION IN PEDIATRIC PRACTICE
by: O. I. Simonova
Published: (2011-01-01)

ADMINISTRATION OF MUCOLYTICS WITH DIRECT ACTION IN PEDIATRIC PRACTICE
by: O. I. Simonova
Published: (2011-01-01)

AMBROXOL IN THE THERAPY OF THE RESPIRATORY PATHOLOGY AMONG CHILDREN
by: O.I. Simonova
Published: (2007-11-01)

THE VALUE OF THE COMPOUND DRUGS FORMOTEROL AND IPRATROPIUM BROMIDE IN COMPLEX TREATMENT OF CHRONIC NONSPECIFIC LUNG DISEASES IN CHILDREN
by: O.I. Simonova
Published: (2006-03-01)

THE PLACE OF KINESITHERAPY IN BASIC TREATMENT OF CHRONIC NONSPECIFIC PULMONARY DISEASES IN CHILDREN: NEW METHODS, MISTAKES AND DIFFICULTIES
by: O.I. Simonova
Published: (2010-07-01)

NEW MEDICINAL FORM IN TREATMENT OF BRONCHIAL ASTHMA: FIXED COMBINATION OF FORMOTEROL AND BECLOMETASONE
by: O.I. Simonova
Published: (2010-05-01)

Cannot write session to /tmp/vufind_sessions/sess_6fttqit5jioh6o916n7r45tuuq